软雾吸入剂研究进展及挑战OA
Research progress in soft mist inhalers and challenges
因肺部独特的生理结构,肺部给药在治疗肺部和全身疾病方面相较于口服和注射给药途径显示出特定优势,受到广泛关注.尽管传统吸入制剂能够实现肺部药物递送,但仍存在肺部沉积率低、操作便捷性差、碳排放较高及患者依从性不佳等局限.作为一种新型吸入装置,软雾吸入剂(SMI)显示出一定优势和潜力.该文通过文献分析及专利梳理,概述了SMI的气溶胶特性与技术原理,总结了其起源、核心优势和临床价值,分析了其在剪切敏感型制剂中的应用潜力,并列举了近期相关代表性专利成果.同时,简述了SMI在药物溶液配方优化、喷嘴设计精度提升和生产成本控制等方面面临的挑战,并基于现有专利成果,对其未来发展提出了建议.
Given the unique physiological structure of lungs,pulmonary drug delivery has distinct advantages over oral or injectable administration routes for treating both pulmonary and systemic diseases,hence increasing interest in related research.Despite the ability to achieve pulmonary drug delivery,conventional inhalable formulations have such limitations as low rates of pulmonary deposition,a lack of user-friendliness,relatively high carbon emissions,and poor patient compliance.As a novel inhalation device,soft mist inhalers(SMIs)promise good potential and advantages.This article outlines the aerosol characteristics and principles of SMIs,summarizes their origins,leading advantages,and clinical value,and analyzes its applications in shear-sensitive formulations based on related literature and patents.Recent representative patents related to SMIs are listed.Furthermore,the challenges facing the development of SMIs are discussed,involving the optimization of drug solution formulations,enhancement of nozzle design precision,and reduction of production costs.Future developments are also predicted.
任博;王利宾;刘春媛;刘春艳;郑爱萍
华北理工大学药学院,河北 唐山 063210华北理工大学药学院,河北 唐山 063210华北理工大学药学院,河北 唐山 063210华北理工大学药学院,河北 唐山 063210军事科学院军事医学研究院,北京 100850
医药卫生
软雾吸入剂肺部给药吸入装置技术优势研究进展
soft mist inhalerpulmonary drug deliveryinhalation devicestechnical advantagesresearch progress
《军事医学》 2026 (8)
635-640,6
评论